Pretreatment Thrombocytosis as a Prognostic Factor in Metastatic Breast Cancer
Background. An elevated platelet count is often associated with malignancies, and it has been confirmed as an adverse prognostic factor in various cancers including early stage breast cancer. We sought to determine if thrombocytosis is also a prognostic factor in metastatic breast cancer. Patients a...
Saved in:
Main Authors: | Athina Stravodimou, Ioannis A. Voutsadakis |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | International Journal of Breast Cancer |
Online Access: | http://dx.doi.org/10.1155/2013/289563 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Approach to the Investigation of Thrombocytosis: Differentiating between Essential Thrombocythemia and Secondary Thrombocytosis
by: Ala Almanaseer, et al.
Published: (2024-01-01) -
Indicative value of RDW/MCV in pseudo-thrombocytosis
by: Na Chen, et al.
Published: (2025-02-01) -
Prognostic factors in hereditary breast cancer: A review
by: Ziske Maritska, et al.
Published: (2024-08-01) -
Pretreatment Hemoglobin Level Is an Independent Prognostic Factor in Patients with Lung Adenocarcinoma
by: Yue-Hua Zhang, et al.
Published: (2018-01-01) -
Acute Limb Ischemia in the Young: A Rare Case of Essential Thrombocytosis
by: Johanes Nugroho, et al.
Published: (2021-01-01)